New hires for VIVA! Communications

Leading independent health + wellness communications agency, VIVA! Communications Pty Ltd, is pleased to announce the appointment of Julia Slater as Senior Account Director. Julia is charged with leading a number of multi-national pharmaceutical clientele across VIVA! Communications’ portfolio. Her responsibilities will include growing the agency’s core ethical healthcare practice, building even stronger relationships with…

Read More

Seqirus joins international vaccine venture to develop long-lasting, universal flu vaccine

Seqirus (owned by CSL) has joined an international, non-profit venture dedicated to decoding the immune system to develop a universal flu vaccine that affords long-lasting protection against seasonal and pandemic influenza across demographics and geography. The Human Vaccines Project aims to decode the human immune system to accelerate development of vaccines and immunotherapies against major…

Read More

Early screening crucial to beating bowel cancer

Bowel cancer is Australia’s third most common type of newly diagnosed cancer 15,253 Australians are diagnosed annually with bowel cancer 4,346 of those die from bowel cancer each year, making it the second biggest cancer killer (behind only lung cancer) These are just some of the shocking statistics shared by Bowel Cancer Australia this Bowel…

Read More

Influencing the digital landscape

VIVA! Communications’ Principal, Kirsten Bruce, had the pleasure of presenting to Melbourne’s leading pharma marketers about how to influence the digital landscape at the Melbourne Pharma Marketing (MPM) breakfast seminar, hosted by Princeton Digital, at The Cullen Prahran, Melbourne on Monday, June 20, 2018. Entitled Marketing reinvented: New rules and new tools in this digital…

Read More